Answers are grounded in this paper and cite their sources.
The AIXA Osteo model architecture (X1AI-Osteo) has undergone internal validation in Taiwan, demonstrating its capability to evaluate osteoporosis and predict T-scores reliably. Nonetheless, its efficacy in alternative clinical environments has not been confirmed yet. This study uses real-world data from a Japanese clinical environment to externally evaluate the AIXA Osteo model and improves upon common image capture discrepancies in cross-domain applications and diagnostic variability arising from disparate reference databases. We used a structure-preserving CycleGAN and a large-mask inpainting model to enhance the quality of radiographs and restored regions with missing areas. Additionally, the T-scores between NHANES III and Asian standards were reconciled through a feature fusion module. In a validation set of 300 participants, preprocessing improved the area under the curve of the model from 92.9% to 97.2%, sensitivity from 88.6% to 95.7%, and the positive predictive value from 80.5% to 90.5%. With respect to the T-score prediction performance, the consistency correlation coefficient between model and dual-energy X-ray absorptiometry measurements improved from 0.956 to 0.994. These findings indicate that the proposed framework for image preprocessing and the feature fusion module support the application of X-ray-based artificial intelligence for osteoporosis screening in heterogeneous clinical environments.
No takes yet. Share an insight, caveat, or question.
片桐洋樹 et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: